Immunostaining revealed lower NS1-BP expression in the primary lesions in the training cohort that consisted of 144 patients with advanced ESCC versus 30 normal esophageal mucosa tissues (Fig. 1b–f). This evidence concerns the gene IVNS1ABP and esophageal squamous cell carcinoma.